Eight Canadian healthtech companies part of initial MedTeq fund investments
Summary
Optina Diagnostics (Montreal, QC), is focused on the development of technology for the early detection of diseases through hyperspectral imaging of the retina. Thorasys (Montreal, QC), has developed portable devices for lung function screening, diagnostics, and monitoring that provide clinically relevant information in patients of all ages. “MedTeq is seeking to financially support health-technology companies across Canada who share our vision that a collaborative approach de-risks health products and services,” said Jacques Milette, president of MedTeq’s board of directors. “Starting in Quebec…we are looking forward to developing opportunities in British Columbia, Ontario, Alberta, Manitoba and Saskatchewan in the months to come.” One issue MedTeq tries to address with its investments is around procurement, promoting collaboration between stakeholders, including doctors, insurance companies, hospitals, or any potential acquirer. Reports have noted that practices within digital health have become increasingly centralized, resulting in a smaller number of opportunities for healthtech companies to see their technologies go to market.